ArticlePharmaceutics2019

Characterization of a Reservoir-Style Implant for Sustained Release of Tenofovir Alafenamide (TAF) for HIV Pre-Exposure Prophylaxis (PrEP).

Leah M Johnson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.